Dr. Aaron Meyer earned his B.S. in bioengineering from the University of California, Los Angeles in 2009, followed by his Ph.D. in biological engineering from MIT. During his doctoral thesis work in the labs of Douglas Lauffenburger and Frank Gertler, he identified new ways to screen for processes that drive metastasis and improved our understanding of how to target signaling from TAM receptors. Dr. Meyer has received awards from the Siebel Scholars Foundation, National Science Foundation, and Department of Defense, to support his work. In 2014, he received an NIH Director’s Early Independence Award, a NIH Common Fund grant aimed at accelerating the independent careers of promising young scientists.
At his State of the Union address, President Obama announced the creation of a Precision Medicine Initiative. While exact details of its implementation are still being decided, what has been described centers around the creation of a million individual database, along with broad characterization of variation among these individuals, so that genomic (and other […]